PRKN and melanoma: In parallel, Lee et al. have recently used an elaborate syngeneic model of B16-F10 melanoma cells injected in a transgenic Parkin knock-out mouse and assessed that Parkin favors melanoma growth and distal metastases by preventing the activation of the apoptotic cascade (Figure 1B) (69).